Benzinga
搜索文档
Crude Oil Down 2%; Abbott Shares Fall Following Q4 Results - Abbott Laboratories (NYSE:ABT), C3is (NASDAQ:CISS)
Benzinga· 2026-01-23 01:02
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Thursday.The Dow traded up 0.78% to 49,462.35 while the NASDAQ gained 0.94% to 23,443.19. The S&P 500 also rose, gaining, 0.63% to 6,918.78.Check This Out: How To Earn $500 A Month From Goldman Sachs Stock Ahead Of Q4 EarningsLeading and Lagging SectorsCommunication services shares gained by 1.3% on Thursday.In trading on Wednesday, utilities stocks dipped by 0.5%.Top HeadlineAbbott Laboratories (NYSE ...
Crude Oil Down 2%; Abbott Shares Fall Following Q4 Results
Benzinga· 2026-01-23 01:02
美股市场表现 - 美股午盘交易走高 纳斯达克综合指数上涨超过200点[1] - 道琼斯指数上涨0.78%至49,462.35点 纳斯达克指数上涨0.94%至23,443.19点 标普500指数上涨0.63%至6,918.78点[1] - 通信服务板块领涨 周四上涨1.3%[1] 个股动态 - 雅培实验室股价下跌超过7% 因第四季度销售额及第一季度盈利展望低于预期[2] - 雅培实验室第四季度销售额为114.6亿美元 略低于市场预期的118亿美元 报告销售额增长4.4% 有机增长率为3% 若剔除新冠检测相关销售则增长3.8%[2] - 雅培实验室调整后每股收益为1.50美元 符合华尔街预期[3] - 60 Degrees Pharmaceuticals股价飙升158%至5.15美元 因宣布与Runway Health建立合作伙伴关系[9] - Eagle Bancorp股价上涨18%至28.25美元 因第四季度财务业绩超预期[9] - Creative Media & Community Trust股价上涨52%至4.4494美元 因宣布完成其贷款部门的出售[9] - C3is Inc.股价下跌37%至0.088美元 因公司宣布1股合20股的反向股票分割[9] - Mingteng International股价下跌34%至0.020美元 因公司宣布1股合200股的反向股票分割[9] - POET Technologies股价下跌12%至7.35美元 因公司宣布1.5亿美元的股票发行计划 涉及2,069万股[9] 行业板块 - 公用事业股在周三交易中下跌0.5%[1] 商品市场 - 油价下跌2.1%至每桶59.37美元 金价上涨0.6%至每盎司4,864.60美元[6] - 银价上涨2.7%至每盎司95.135美元 铜价下跌0.4%至每磅5.7435美元[6] 全球市场 - 欧洲股市普遍上涨 欧元区STOXX 600指数上涨1.09% 西班牙IBEX 35指数上涨1.01% 英国富时100指数上涨0.26% 德国DAX指数上涨1.19% 法国CAC 40指数上涨1.12%[7] - 亚洲股市周四收高 日本日经225指数上涨1.73% 香港恒生指数上涨0.17% 中国上证综合指数上涨0.14% 印度BSE Sensex指数上涨0.49%[8] 宏观经济数据 - 美国截至1月17日当周初请失业金人数增加1,000人至20万人[11] - 美国第三季度经济年化增长率为4.4% 高于初步估计的4.3% 为2023年第三季度以来最强劲增长[11] - 美国11月个人收入环比增长0.3%至26.403万亿美元 10月为增长0.1%[11] - 美国11月个人支出环比增长0.5%至年化21.410万亿美元 前月亦为增长0.5%[11] - 美国11月PCE价格指数环比上涨0.2% 与前月持平 符合市场预期[11]
DraftKings, Flutter In Focus As BofA Sees Online Betting Driving Gaming Stocks Into 2026
Benzinga· 2026-01-23 00:55
行业整体趋势与表现 - 博彩行业在2026年初,投资者的关注焦点仍集中在在线体育博彩上,尽管拉斯维加斯、区域性赌场和亚洲市场的疲软趋势抑制了近期预期 [1] - 第四季度及至1月份,博彩类股票整体下跌约9%,其中美国运营商下跌约4%,澳门博彩股下跌13%,数字和在线博彩股下跌23% [3] - 12月份数据显示,在线博彩、拉斯维加斯酒店指标和区域性赌场均表现疲软 [3] 在线博彩 - 美银证券对DraftKings的盈利预测高于市场共识,但对FanDuel的预测低于市场共识 [4] - 虽然博彩公司赢率(hold rates)意外向好,但12月和1月较弱的投注额(betting handle)重新引发了市场对促销强度和利润率风险的担忧 [4] - DraftKings有望在第四季度业绩大幅超出预期,而FanDuel面临更大压力 [4] 拉斯维加斯市场 - 第四季度整体预测略低于市场预期,拉斯维加斯大道(the Strip)的综合预测比市场共识低约1%,对美高梅国际酒店集团的预测比共识低约2% [5] - 博彩收入保持稳定,但每间可用客房收入(RevPAR)和客流量持续疲软,12月份表现尤为疲软 [5] - 预计第一季度仍将承压,第二季度起同比基数将变得更容易 [5] - 拉斯维加斯本地市场(Las Vegas locals)持续表现良好,美银证券的预测高于市场共识 [6] 亚洲市场 - 澳门第四季度息税折旧摊销前利润(EBITDA)预计将大致符合市场预期 [7] - 收入增长稳健,美银证券的预测略高于共识,主要受美高梅中国强劲表现驱动 [7] - 投资者的关注点可能转向拉斯维加斯金沙集团的市场份额趋势,以及从第二季度开始的更具挑战性的同比比较 [7] - 新加坡方面,得益于一级方程式赛事移至第四季度以及酒店指标改善,滨海湾金沙酒店可能小幅超出预期 [8] 区域性赌场 - 美银证券对区域性赌场的预测略高于市场共识,主要由美高梅国际酒店集团和博伊德游戏公司引领 [8] - 然而,由于路易斯安那州竞争加剧,宾夕法尼亚娱乐公司可能表现疲软 [8] - 同店博彩收入趋势在整个季度有所放缓 [9] - 凯撒娱乐公司的业绩表明促销强度可能正在趋于平稳,这可能长期支撑利润率 [9]
What's Going On With Rocket Lab Stock Today
Benzinga· 2026-01-23 00:21
Rocket Lab Corporation (NASDAQ:RKLB) shares are trading lower on Thursday. The company disclosed that it completed its first launch of 2026 and its 80th Electron mission overall.DetailsThe mission, titled The Cosmos Will See You Now, lifted off from Rocket Lab Launch Complex 1 in Mahia, New Zealand, at 11:52 pm NZDT (10:52 UTC).It deployed two satellites into a 1,050 km circular orbit for the first time, dedicated to a customer, Open Cosmos.Open Cosmos, a pan-European space tech firm, delivers complete sate ...
These Analysts Increase Their Forecasts On Prologis After Q4 Results - Prologis (NYSE:PLD)
Benzinga· 2026-01-23 00:19
Prologis Inc. (NYSE:PLD) reported weak revenue for its fourth quarter on Wednesday.Rental and other revenue came in at $2.10 billion, falling short of the analyst consensus estimate of $2.148 billion.Core funds from operations (FFO) declined to $1.44 from $1.50 in the prior-year quarter, in line with analyst expectations. Earnings per share improved to $1.49, compared with $1.37 a year ago.For fiscal 2026, Prologis guided for core FFO in the range of $6.00 to $6.20, compared with the consensus estimate of $ ...
These Analysts Increase Their Forecasts On Prologis After Q4 Results
Benzinga· 2026-01-23 00:19
Prologis Inc. (NYSE:PLD) reported weak revenue for its fourth quarter on Wednesday.Rental and other revenue came in at $2.10 billion, falling short of the analyst consensus estimate of $2.148 billion.Core funds from operations (FFO) declined to $1.44 from $1.50 in the prior-year quarter, in line with analyst expectations. Earnings per share improved to $1.49, compared with $1.37 a year ago.For fiscal 2026, Prologis guided for core FFO in the range of $6.00 to $6.20, compared with the consensus estimate of $ ...
BankUnited Analysts Raise Their Forecasts After Upbeat Q4 Earnings - BankUnited (NYSE:BKU)
Benzinga· 2026-01-23 00:15
BankUnited, Inc. (NYSE:BKU) reported better-than-expected fourth-quarter financial results on Wednesday.BankUnited reported quarterly earnings of 94 cents per share which beat the analyst consensus estimate of 88 cents per share. The company reported quarterly sales of $288.203 million which beat the analyst consensus estimate of $280.052 million.“We are pleased to report strong fourth quarter earnings, concluding an outstanding year for BankUnited. We continue to execute our organic growth strategy which h ...
BankUnited Analysts Raise Their Forecasts After Upbeat Q4 Earnings
Benzinga· 2026-01-23 00:15
BankUnited, Inc. (NYSE:BKU) reported better-than-expected fourth-quarter financial results on Wednesday.BankUnited reported quarterly earnings of 94 cents per share which beat the analyst consensus estimate of 88 cents per share. The company reported quarterly sales of $288.203 million which beat the analyst consensus estimate of $280.052 million.“We are pleased to report strong fourth quarter earnings, concluding an outstanding year for BankUnited. We continue to execute our organic growth strategy which h ...
Corcept Therapeutics Experimental Lead Drug Cuts Death Risk By 35% In Advanced Ovarian Cancer Patients, Stock Jumps
Benzinga· 2026-01-23 00:12
Corcept Therapeutics Incorporated (NASDAQ:CORT) stock is trading higher on Thursday, with a session volume of 3.06 million.The company’s ROSELLA Phase 3 trial of relacorilant plus nab-paclitaxel to treat patients with platinum-resistant ovarian cancer met its overall survival (OS) primary endpoint.DataIn ROSELLA, patients treated with relacorilant in addition to nab-paclitaxel chemotherapy experienced a 35% reduction in the risk of death compared to patients treated with nab-paclitaxel alone (hazard ratio: ...
These Analysts Increase Their Forecasts On Wintrust Financial After Strong Q4 Earnings
Benzinga· 2026-01-23 00:10
Wintrust Financial Corporation (NASDAQ:WTFC) reported better-than-expected fourth-quarter financial results, after the closing bell on Tuesday.Wintrust Finl reported quarterly earnings of $3.15 per share which beat the analyst consensus estimate of $2.92 per share. The company reported quarterly sales of $714.264 million which beat the analyst consensus estimate of $700.352 million.Timothy S. Crane, President and Chief Executive Officer, said, “We are pleased with our strong 2025 results, including the 19% ...